Fig. 3
From: Urine-based multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Proteomics-based mortality signature. a Differentially abundant proteins in COVID-19 survivors and non-survivors, as observed in two bodily fluids, urine (n = 42) and plasma (n = 43, one additional patient). 60 proteins were significant in urine proteomic profiles, while none of the proteins measured in the plasma of the same patients were associated with mortality. b Top 14 differential proteins from COVID-19 urine-based mortality signature with log2 fold change larger than or equal to 2 at 5% FDR